Inventor · disambiguated record
Henrik Oestergaard
Also filed as: OESTERGAARD HENRIK
9 granted patents·18 pending applications·17 citations·filing 2011–2024
83Inventor score
Top patents by PatentIndex Score
27 records- 0192US11325983B2Bispecific antibodiesNOVO NORDISK AS·Filed 2021·Granted May 10, 2022·2 cites·9 claims
- 0290US9370583B2Coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2015·Granted Jun 21, 2016·4 cites·10 claims
- 0386US11220554B2Procoagulant antibodiesNOVO NORDISK AS·Filed 2021·Granted Jan 11, 2022·2 cites·26 claims
- 0480US9062115B2Therapeutic factor VIII antibodiesOESTERGAARD HENRIK·Filed 2011·Granted Jun 23, 2015·6 cites·12 claims
- 0578US9371370B2Coagulation factor VII polypeptidesNOVO NORDISK AS·Filed 2014·Granted Jun 21, 2016·2 cites·15 claims
- 0674US12122847B2Factor VII (FVII(a))/TREM-like transcript 1 (TLT-1) bispecific antibodiesNOVO NORDISK AS·Filed 2022·Granted Oct 22, 2024·0 cites·6 claims
- 0772US2022073895A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 0871US2025011468A1Procoagulant AntibodiesNOVO NORDISK AS·Filed 2024·Application pending·0 cites
- 0963US8859731B2Selective modification of proteinsKOFOD-HANSEN MIKAEL·Filed 2011·Granted Oct 14, 2014·1 cites·12 claims
- 1063US2018142227A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2018·Application pending·0 cites
- 1162US2020010820A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 1259US10179905B2Factor VII conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2017·Granted Jan 15, 2019·0 cites·14 claims
- 1359US2015259665A1Factor vii conjugatesNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 1459US2017096655A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2016·Application pending·0 cites
- 1556US2013040888A1Factor VIII Molecules With Reduced VWF BindingNOVO NORDISK AS·Filed 2011·Application pending·0 cites
- 1655US2017198274A1Human Coagulation Factor VII PolypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2017·Application pending·0 cites
- 1755US2017020992A1Factor VIII Molecules with Reduced VWF BindingNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 1853US2023058721A1Procoagulant AntibodiesNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 1952US2015376262A1Factor VIII Molecules With Reduced VWF BindingNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 2051US2016264645A1Stabilized Factor VIII VariantsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2150US12084512B2Procoagulant antibodiesNOVO NORDISK AS·Filed 2018·Granted Sep 10, 2024·0 cites·5 claims
- 2250US2016251409A1Targeted Delivery of Factor VIII Proteins to PlateletsNOVO NORDISK AS·Filed 2016·Application pending·0 cites
- 2345US2013183280A1Stabilized factor viii variantsOESTERGAARD HENRIK·Filed 2011·Application pending·0 cites
- 2445US2015044195A1FVIIa-sTF complexes exhibiting exosite-mediated super activityNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 2543US2015239984A1Therapeutic factor viii antibodiesOESTERGAARD HENRIK·Filed 2015·Application pending·0 cites
- 2641US2015307865A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2013·Application pending·0 cites
- 2739US2016024487A1Thrombin sensitive coagulation factor x moleculesNOVO NORDISK AS·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Henrik Oestergaard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →